Doctors Group Applauds CDC’s Decision to End Monkey Experiments: A Landmark Shift Towards Human-Centric Research
The Physicians Committee for Responsible Medicine (PCRM) is celebrating a significant milestone in the realm of medical ethics and research. The Centers for Disease Control and Prevention (CDC) has made a groundbreaking decision to phase out all research on monkeys, marking a pivotal moment in the history of scientific experimentation.
In a recent development, the CDC has instructed its scientists to discontinue all monkey research, as reported by the journal Science on November 21, 2025 (https://www.science.org/content/article/exclusive-cdc-end-all-monkey-research). This move is a testament to the growing recognition of the limitations and ethical concerns surrounding animal testing, particularly in the context of monkeys.
Janine McCarthy, MPH, the acting director of research policy for PCRM, expressed her enthusiasm for this decision, stating, "For the first time, a U.S. agency is prioritizing modern, human-relevant science over outdated monkey experiments." This shift signifies a paradigm change in the approach to medical research, where the focus is now on methods that better reflect human biology and physiology.
The CDC's decision comes at a critical juncture, as the public health risks associated with monkey experimentation have become increasingly evident. Over the past two decades, numerous monkey escapes from U.S. research facilities and transport have been reported, posing significant zoonotic disease risks to laboratory workers, first responders, transport personnel, and nearby communities. These incidents have underscored the urgent need for safer and more ethical research practices.
Furthermore, the scientific community has long debated the limitations of monkey research. It is well-documented that approximately 92% of drugs that show promise in animal testing, often involving primates, fail to translate to human safety or efficacy. This discrepancy highlights the need for more accurate and human-relevant models in drug development.
While the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) have acknowledged the importance of reducing animal research, they continue to conduct experiments on monkeys. PCRM is urging these agencies to accelerate the transition to modern, human-based methods such as organoids, organ chips, and other advanced technologies that better mimic human biology and disease processes.
In addition to the scientific and ethical considerations, PCRM emphasizes the need for dedicated federal funding to ensure the safe and humane placement of the approximately 200 macaques currently housed in CDC facilities. The organization believes that sanctuary placement is crucial for completing the transition away from primate research responsibly and transparently.
A survey conducted by PCRM and Morning Consult (https://pcrm.widen.net/s/qzfxtfh7bw/animal-testing-survey) revealed that a vast majority of respondents favor phasing out animal experiments in favor of other human-relevant research methods. This public sentiment underscores the growing demand for more ethical and human-centric approaches in medical research.
In conclusion, the CDC's decision to end monkey experiments is a significant step towards a more ethical and effective research paradigm. PCRM's advocacy and the public's support for this shift demonstrate a collective commitment to advancing medical science while prioritizing human welfare and ethical standards.
